Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Here we report the engineering and preclinical development of a bimodal molecule that integrates NMDA receptor antagonism with glucagon-like peptide-1 (GLP-1) receptor agonism to effectively reverse obesity, hyperglycaemia and dyslipidaemia in rodent models of metabolic disease
Barry Conrad Hmm, yep
Un amplio corpus cientfico La L-Tartrato es la forma ms estudiada cientficamente en el contexto deportivo
Presented for research literature review only Chen F et al
US$ 26.00
US$ 25.58
US$ 29.34
US$ 21.87
US$ 27.46
US$ 26.97
